eGenomics provides its strain library and DNA typing services to pharmaceutical companies who wish to test new antibiotics, vaccines and other treatment options against a genetically diverse group of pathogens.

Because the eGenomics system distinguishes among similar pathogens, pharmaceutical companies can ensure that in vitro testing of new drugs are conducted against dissimilar organisms.